Virpax Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 7.87
| VRPX Stock | USD 0.47 0.10 17.54% |
Virpax |
Virpax Pharmaceuticals Target Price Odds to finish over 7.87
The tendency of Virpax Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 7.87 or more in 90 days |
| 0.47 | 90 days | 7.87 | close to zero percent |
Based on a normal probability distribution, the odds of Virpax Pharmaceuticals to move over $ 7.87 or more in 90 days from now is close to zero percent (This Virpax Pharmaceuticals probability density function shows the probability of Virpax Stock to fall within a particular range of prices over 90 days) . Probability of Virpax Pharmaceuticals price to stay between its current price of $ 0.47 and $ 7.87 at the end of the 90-day period is about 99.0 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.76 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Virpax Pharmaceuticals will likely underperform. Additionally Virpax Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Virpax Pharmaceuticals Price Density |
| Price |
Predictive Modules for Virpax Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Virpax Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Virpax Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Virpax Pharmaceuticals is not an exception. The market had few large corrections towards the Virpax Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Virpax Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Virpax Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.46 | |
β | Beta against Dow Jones | 1.76 | |
σ | Overall volatility | 0.10 | |
Ir | Information ratio | -0.05 |
Virpax Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Virpax Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Virpax Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Virpax Pharmaceuticals generated a negative expected return over the last 90 days | |
| Virpax Pharmaceuticals has high historical volatility and very poor performance | |
| Virpax Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Virpax Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (15.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Virpax Pharmaceuticals currently holds about 26.06 M in cash with (9.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Virpax Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from businesswire.com: Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur |
Virpax Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Virpax Stock often depends not only on the future outlook of the current and potential Virpax Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Virpax Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.2 M | |
| Cash And Short Term Investments | 9.1 M |
Virpax Pharmaceuticals Technical Analysis
Virpax Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Virpax Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Virpax Pharmaceuticals. In general, you should focus on analyzing Virpax Stock price patterns and their correlations with different microeconomic environments and drivers.
Virpax Pharmaceuticals Predictive Forecast Models
Virpax Pharmaceuticals' time-series forecasting models is one of many Virpax Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Virpax Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Virpax Pharmaceuticals
Checking the ongoing alerts about Virpax Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Virpax Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Virpax Pharmaceuticals generated a negative expected return over the last 90 days | |
| Virpax Pharmaceuticals has high historical volatility and very poor performance | |
| Virpax Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Virpax Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (15.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Virpax Pharmaceuticals currently holds about 26.06 M in cash with (9.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Virpax Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from businesswire.com: Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur |
Additional Tools for Virpax Stock Analysis
When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.